ISTA PHARMACEUTICALS –

Irvine, Calif.

Went public 8/22/2000 at $10.50 per share

Filing Range: 3 mil. shares @ $13 to $15

Shares Outstanding: 15.9 mil. shares

Underwriters: CIBC World Markets/Prudential Vector Healthcare/Thomas Weisel Partners LLC

Company Counsel: Wilson Sonsini Goodrich & Rosati

Manager Counsel: Skadden, Arps, Slate, Meagher & Flom

Auditor: Ernst & Young LLP

The Company:

Develops contact lens to reshape the cornea and restore visual acuity without surgery. The company is currently conducting domestic and international clinical trials on Vitrase (a drug designed to rapidly clear vitreous hemorrhage) and on Corneaplasty (a non-surgical system to correct refractive vision errors.)

Venture Backers:

Sanderling Ventures

Invesco Private Capital

Domain Associates LLC

Financing Rounds:

Number of Round Amt.

Round # Round Date Stage Investors ($ thousands)

1 08/16/1995 1 Later Stage 217.0

2 10/18/1995 1 Early Stage1 742.0

3 06/30/1997 3 Expansion 15000.0

4 09/28/1998 4 Later Stage 1000.0

5 11/17/1998 4 Expansion 5999.0

6 03/14/1999 4 Expansion 3000.0

Financials:

(Data in $ millions)

Y/E

12/31/99

Total Revenues: $0.0

Net Income: -14.3